Oliver’s Real Food (ASX:OLI) announced that its same store sales for August 2023 were 11.25% higher than those of the previous year.
Oliver’s Real Food is a health-conscious fast-food chain offering a variety of fresh, natural foods.
The Director's Commentary of the ASX.
Receive whispers every day in your inbox.
Oliver’s Real Food (ASX:OLI) announced that its same store sales for August 2023 were 11.25% higher than those of the previous year.
Oliver’s Real Food is a health-conscious fast-food chain offering a variety of fresh, natural foods.
Allkem (ASX:AKE) has released an announcement regarding an increase in the estimated development capital cost for their Sal De Vida Project.
The previously reported estimate was US$271 million.
According to the new study, the estimate has now increased to US$374 million.
Pre-commissioning and commissioning activities for the project are expected to occur in H1 CY25, with the first production expected in H2 CY25.
Allkem is a company involved in various fields, including but not limited to, manufacturing and distribution of chemical and mineral resources.
Australian gold stocks, represented by the index AXGD, have been observed to decline as much as 2.1% today.
If losses continue, it could be their worst performance since September 5.
The fluctuations seem to follow after gold’s minor 0.1% gain last week, as investors continued to process warnings from U.S.
Federal Reserve officials about potential further interest rate hikes.
Notably affected, Northern Star Resources (ASX:NST) has seen a drop of nearly 2.6%.
Similarly, Newcrest Mining (ASX:NCM) experienced a decline of about 1.2%.
Additionally, Bellevue Gold (ASX:BGL) and Capricorn Metals (ASX:CMM) have both recorded over 4% reductions.
Despite these movements, the AXGD has still risen roughly 13% this year, in comparison to the 0.4% increase in the benchmark index.
Northern Star Resources (ASX:NST) is an industry major in the Australian gold production market.
Shares in oncology firm Imugene (ASX:IMU) have risen by up to 6% to A$0.053, indicating the potential for their best day since September 15 pending continued gains.
The company recently closed the Share Purchase Plan of its capital raising for the acquisition of exclusive licensing rights to the cancer drug azer-cel.
This move has raised an additional A$18.2 million ($11.73 million).
Under the Share Purchase Plan, about 325 million shares will be issued at A$0.056 per share.
According to LSEG data, two out of two analysts rate the stock as a ‘Buy’, with a median price target of A$0.51.
The stock is positioned for gains after three consecutive sessions of losses should the gains persist.
The stock is down 65.5% year-to-date as of the last closure.
Imugene (ASX:IMU) is an oncology company that focuses on developing and commercializing novel cancer treatments.
Shares of Codrus Minerals (ASX:CDR) fell sharply as much as 14.1% to A$0.079, dipping to its lowest level since September 18.
If these losses hold, it could be Codrus’s worst trading day since August 28.
The company, a gold miner, announced it has received commitments to raise A$0.92 million through an equity placement.
Codrus said the placement was issued at 8 Australian cents per share, which is a 13% discount to its latest closing price.
The stock has seen a decline of 29.2% this year, up until its most recent closing.
Codrus Minerals (ASX:CDR) is a gold mining enterprise.
Redflow (ASX:RFX) shares rise as much as 8.2% to A$0.298, reaching their highest level since September 19.
The electrical equipment manufacturer announces the U.S.
Department of Energy’s approval of funding for a 34.4 megawatt-hour long-duration energy storage microgrid project.
The project will be a part of the Department’s $325 million long-duration energy storage program, an initiative aimed at the advancement of crucial clean energy technologies.
Trading also sees heightened activity, with more than 481,000 shares changing hands, significantly surpassing the 30-day average volume of 171,651 shares.
The year has been generally positive for the stock, showcasing a rise of 27.9% as of the last close.
Redflow is an electrical equipment manufacturer specializing in the development and production of energy storage systems.
Shares of Qantas Airways (ASX:QAN) decrease as much as 2.26% to A$5.180, hitting their lowest value since October 12, 2022.
The airline company stated that increasing fuel prices are anticipated to surmount its fuel expenditures by around A$200 million ($128.88 million) in the initial half of FY2024.
Additionally, the company projects an extra A$50 million impact due to non-fuel-related foreign exchange fluctuations in the first six months of the current fiscal year.
Out of 15 analysts, 13 rate the stock ‘buy’ or higher while two suggest ‘hold’, and their median price target is A$8.69 based on LSEG data.
If the degradation persists, the stock is poised for its worst daily performance since September 7.
Further, if the declining trend continues, it will be the fifth consecutive trading session of losses.
As of the last close, QAN shares are down 11.7% for the year.
Qantas Airways (ASX:QAN) is an Australian flag carrier that provides international and domestic air travel services.
Shares in Orica, a noted mining and infrastructure solution provider, fell significantly by as much as 1.8% to reach A$15.150.
The dip can be attributed to the impending shutdown of the company’s key Kooragang Island facility.
For analysts at Citi, this closure arrives at a rather untimely phase when they forecasted a rise in demand for explosives and their prices.
They noted that during an 8-9 weeks turnaround period, the company’s ammonia plant, a major part of its operations, will not be functional.
Citi claims that this could necessitate the import of ammonium nitrate by Kooragang to sustain market demands for FY24.
The resulting diminished manufacturing margin is projected around A$15 million.
Following evaluation of the scenario, Citi reduced its FY24 underlying EBIT estimate by 4%.
Regardless, the majority of analysts remain optimistic about Orica’s performance with eleven of thirteen analysts designating a ‘buy’ or higher rating.
One analyst maintains a ‘hold’ while one suggests a ‘sell’, endorsing a median price target of A$17.80.
As of its last traded session, the stock recorded a 1.1% gain this year.
Orica (ASX:ORI) is primarily engaged in manufacturing commercial explosives and blasting systems for the mining, quarrying, and construction sectors.
Financial markets remained cautious due to fears of possible interventions following a weak yen.
Officials from the U.S.
Federal Reserve continued to emphasize higher-for-longer interest rates, a message that was solidified in the central bank’s policy meeting held last week.
Business activity data from around the world offered more proof of the U.S.
economy surpassing other major economies, elevating the U.S.
dollar as the Japanese yen largely weakened due to the Bank of Japan maintaining its dovish policy stance.
Wall Street experienced a downturn, alongside easing Treasury yields after multi-year highs, and mixed results for commodities.
Upcoming light economic and policy matters in Asia suggest that trading might be influenced by potential interventions from Japan to support the yen and the ongoing uncertainties in China’s property market, underscored by Evergrande’s continued debt restructuring issues.
U.S.
stocks experienced a decrease due to a hawkish Federal Reserve, with the Dow Jones dropping by 0.31%, S&P 500 by 0.25%, and Nasdaq by 0.09%.
U.S.
yields ended lower after a strong rally throughout the week; 2-year yields decreased by 2 basis points to 5.1230% after reaching a 17-year peak, 10-year by 4 basis points to 4.4400%, and 30-year by 3 basis points to 4.5220%.
Oil prices increased due to supply concerns; Brent remained steady, while WTI increased by 0.5%.
U.S.
copper remained stable, and gold prices slightly rose as U.S.
yields declined.
The U.S.
dollar, strengthened by the resilience of the U.S.
economy, gained 0.20%, with the euro steady, USD/JPY up 0.55%, GBP down 0.45%, USD/CHF up 0.30%, but AUD up 0.35%, NZD up 0.50%, USD/CAD steady, and USD/CNH down 0.20%.
Qantas Airways (ASX:QAN) recently announced it will invest an additional A$80 million in customer improvements in FY24.
This investment is aimed at addressing several customer ‘pain points’ through enhancements and upgrades.
Despite the global travel climate, Qantas noted that overall travel demand remains steady, with trading conditions in Q1 of FY24 resembling those of the last quarter of FY23.
Both Qantas and Jetstar anticipate accommodating over 4 million passengers during the September/October school holidays.
An increase of approximately A$200 million to a total of A$2.8 billion, after hedging, is expected in the group’s 1H24 fuel bill.
Additionally, a further A$50 million impact is anticipated due to non-fuel-related foreign exchange changes in 1H24.
Both international and domestic capacity for 1H24 is projected to remain largely consistent with estimates given in late August 2023.
New aircraft deliveries and wet-leasing arrangements to Qantas and Jetstar will augment international capacity by 12 percentage points by end of the calendar year.
Qantas also stated its on-market share buyback of up to A$500 million, announced on 24 August, is now 10 percent completed.
Qantas Airways is a major Australian airline, renowned for its domestic and international flight services.